Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults

Journal of Clinical Psychopharmacology

Volumn 19, Issue 6, 1999, Pages 506-512

  File, Sandra E ^a,b   Fluck, Emma ^a   Fernandes, Cathy ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGLYCIN; GLYCINE; UNCLASSIFIED DRUG;

ADULT; AGING; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LEARNING; MALE; MEMORY; MOOD; NEUROPHARMACOLOGY; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AFFECT; AGE FACTORS; ATTENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLYCINE; HUMANS; MALE; MEMORY; MIDDLE AGED; NOOTROPIC AGENTS;

EID: 0032750182     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199912000-00004     Document Type: Article

References (44)

1. Collingridge G. The role of the NMDA receptors in learning and memory. Nature 1987;330:604-5.
2. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by the N-methyl-D-aspartate antagonist. Nature 1986;319:774-6.
3. Ingram DK, Garofalo P, Spangler EL, Mantione CR, Odano I, London ED. Reduced density of NMDA receptors and increased sensitivity to dizolcipine-induced learning impairment in aged rats. Brain Res 1992;580:273-80.
4. Collingridge GL, Bliss TVP. NMDA receptors - their role in long-term potentiation. Trends Neurosci 1987;10:288-93.
5. Monahan JB, Handelmann GE, Hood WF, Cordi AA. D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav 1989;34:649-53.
6. Handelmann GE, Nevins ME, Mueller LL, Arnolde SM, Cordi AA. Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnesic rodents. Pharmacol Biochem Behav 1989;34:823-8.
7. Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine dementia. Ann N Y Acad Sci 1991;640:241-4.
8. Schwartz BL, Hashtroudi S, Herting RL, Handerson H, Deutsch SI. Glycine prodrug facilitates memory retrieval in humans. Neurology 1991;41:1341-3.
9. Schwartz BL, Hashtroudi S, Herting RL, Schwartz BA, Deutsch SI. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology 1996;46:420-4.
10. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996;103:403-28.
11. Raffaele KC, Haxby JV, Schapiro MB. Age-associated memory impairment. In: Racagni G, Mendlewicz J, eds. Treatment of age-related cognitive dysfunction: pharmacological and clinical evaluation. International Academy of Biomedical and Drug Research. Basel, Switzerland: Karger, 1992:69-79.
12. Drachman DA. Memory and cognitive function in normal aging. Dev Neuropsychol 1977;2:277-85.
13. Waterhouse J, Reilly T, Atkinson G. Jet-lag. Lancet 1997;350: 611-6.
14. Quera-Salva MA, Guilleminault C, Claustrat B, Defrance R, Gajdos P, McCann CC, Le Lattre J. Rapid shift in peak melatonin secretion associated with improved performance in short shift work schedule. Sleep 1997;20:1145-50.
15. Fluck E, File SE, Springett J, Kopelman MD, Rees J, Orgill J. Does sedation resulting from sleep deprivation and lorazepam cause similar cognitive deficits. Pharmacol Biochem Behav 1998;59: 909-15.
16. Naegele B, Thouvard V, Pepin J-L, Levy P, Bonnet C, Perret JE, Pellat J, Fuerstein C. Deficits of cognitive executive functions in patients with sleep apnoea. Sleep 1995;18:43-52.
17. Findley L, Univerzagt M, Guchu R, Fabrizio M, Buckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnoea and narcolepsy. Chest 1995;108:619-24.
18. Joyce EM, Blumenthal S, Wessely S. Memory, attention, and executive function in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1996;60:495-503.
19. Fluck, E, Fernandes C, File SE, Curran HV, Marshall J. The influence of alcoholism and cirrhosis on benzodiazepine receptor function. Pharmacol Biochem Behav 1998;59:949-54.
20. Le Moal S, Reymann .JM, Thomas V, Cattenoz C, Liuery A, Allain H. Effect of normal aging and of Alzheimer's disease on episodic memory Dement Geriatr Cogn Disord 1997;8:281-7.
21. Pillon B, Deweer B, Agrid Y, Dubois B. Explicit memory in Alzheimer's, Huntington's and Parkinson's disease. Arch Neurol 1993;50:374-9.
22. Lafosse JM, Reed BR, Mungas D, Sterling SB, Wahbeh H, Jagust WJ. Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease. Neuropsychology 1997;11: 514-22.
23. Dalrymple-Alford JC, Kalders AS, Jones RD, Watson RW. A central executive deficit in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:360-7.
24. Sherwin BB. Estrogen effects on cognition in menopausal women. Neurology 1997;48[suppl 7]:21-6.
25. Bowen DM. Treatment of Alzheimer's disease: molecular pathology versus neurotransmitter-based therapy. Br J Psychiatry 1990; 157:327-30.
26. Nelson H. The National Adult Reading Test-Revised. Windsor: NFER-Nelson, 1992.
27. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974;47:211-8.
28. Weingartner HJ, Joyce EM, Sirocco KY, Adams CM, Eckardt MJ, George T, Lister RG. Specific memory and sedative effects of the benzodiazepine triazolam. J Psychopharmacol 1993;7:305-15.
29. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, London National Foundation for Educational Research, 1981.
30. Gronwall D, Wrightson P. Delayed recovery of intellectual function after minor head injury. Lancet 1974;2:605-9.
31. Craik FIM, Anderson ND, Kerr SA, Li KZH. Memory changes in normal ageing. In: Baddeley AD, Wilson BA, Watts FN, eds. Handbook of memory disorders. London: John Wiley & Sons, 1995: 211-41.
32. Salthouse TA, Toth JP, Hancock HE, Woodard JL. Controlled and automatic forms of memory and attention: process purity and the uniqueness of age-related influences. J Gerontol B Psychol Sci Soc Sci 1997;52:216-28.
33. Nyberg L, Nilsson LG, Olofsson U, Backman L. Effects of division of attention during encoding and retrieval on age differences in episodic memory. Exp Aging Res 1997;23:137-43.
34. Randolph C, Braun AR, Goldberg TE, Chase TN. Semantic fluency in Alzheimer's, Parkinson's, and Huntington's disease: dissociation of storage and retrieval failures. Neuropsychology 1993;7: 82-8.
35. Hartman M. The use of semantic knowledge in Alzheimer's disease: evidence for impairments of attention. Neuropsychologia 1991;29:213-28.
36. Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. J Abnorm Psychol 1992;101:487-94.
37. Duffy L, O'Carroll R. Memory impairment in schizophrenia - a comparison with that observed in the Alcoholic Korsakoff Syndrome. Psychol Med 1994;24:155-65.
38. Joyce EM, Collinson SL, Crichton P. Verbal fluency in schizophrenia: relationship with executive function, semantic memory and clinical alogia. Psychol Med 1996;26:39-49.
39. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A, Kelly D. Double-blind, placebo-controlled crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996;169:610-7.
40. Fleming K, Bigelow LB, Weinberger DR, Goldberg TE. Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychol Bull 1995;31:357-62.
41. Wesnes K, Warburton DM, Matz B. The effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 1983;9:41-4.
42. Nehlig A, Daval J-L, Debry G. Caffeine and the central nervous system: mechanisms of actions, biochemical, metabolic and psychostimulant effects. Brain Res Rev 1992;17:139-70.
43. Stevens DN, Duka T, Andrews JS. Benzodiazepines, betacarbolines and memory. In: Hunter J, Weinman J, eds. Memory: neurochemical and abnormal perspectives. London: Harwood Academic Publishers, 1991:11-41.
44. File SE, Fluck E, Joyce EM. Conditions under which lorazepam can facilitate retrieval. J Clin Psychopharmacol 1999;19:349-53.